Loading...
Algernon Pharmaceuticals Inc.
AGN.CN•CNQ
Healthcare
Biotechnology
CA$0.10
CA$0.00(0.00%)
Algernon Pharmaceuticals Inc. (AGN.CN) Financial Performance & Statements
Review Algernon Pharmaceuticals Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
0.00%
Operating Income Growth
0.00%
Net Income Growth
0.00%
Operating Cash Flow Growth
-6.13%
↓ 6.13%
Operating Margin
0.00%
Gross Margin
0.00%
Net Profit Margin
0.00%
ROE
14.68%
↑ 14.68%
ROIC
-86.16%
↓ 86.16%
Algernon Pharmaceuticals Inc. (AGN.CN) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Algernon Pharmaceuticals Inc. stock.
| Metric | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Cost of Revenue | $50398.00 | $34936.00 | $0.00 | $0.00 |
| Gross Profit | -$50398.00 | -$34936.00 | $0.00 | $0.00 |
| Gross Profit Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
| R&D Expenses | $1.10M | $2.33M | $4.80M | $2.69M |
| SG&A Expenses | $4.15M | $3.73M | $3.25M | $5.99M |
| Operating Expenses | $5.24M | $6.06M | $8.05M | $8.68M |
| Total Costs & Expenses | $5.24M | $6.06M | $8.05M | $8.68M |
| Interest Income | $2097.00 | $2078.00 | $11927.00 | $35075.00 |
| Interest Expense | $0.00 | $2078.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $50398.00 | $34936.00 | $7.88M | $26995.00 |
| EBITDA | -$4.98M | -$6.02M | $0.00 | -$8.54M |
| EBITDA Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Income | -$5.02M | -$6.06M | -$8.05M | -$8.76M |
| Operating Income Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
| Other Income/Expenses (Net) | -$1.76M | $63275.00 | $2.11M | $858457.00 |
| Income Before Tax | -$6.78M | -$6.05M | -$7.73M | -$8.54M |
| Income Before Tax Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
| Income Tax Expense | $0.00 | -$4156.00 | -$11927.00 | -$122848.00 |
| Net Income | -$6.78M | -$6.05M | -$7.72M | -$8.42M |
| Net Income Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
| EPS | -$0.45 | -$0.73 | -$1.04 | -$2.00 |
| Diluted EPS | -$0.45 | -$0.73 | -$1.04 | -$2.00 |
| Weighted Avg Shares Outstanding | $15.15M | $8.30M | $7.44M | $4.21M |
| Weighted Avg Shares Outstanding (Diluted) | $15.15M | $8.30M | $7.44M | $4.21M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan